{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"21","upperLimit":"1430","value":"272"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"100"}],"units":"Participants"}],"dispersionType":"Full Range","groups":[{"description":"ClaPd therapy:\n\nDexamethasone (40mg ) will be given on days 1, 8, 15, 22 of a 28-day cycle. Clarithromycin (Biaxin®) will be given orally at a dose of 500 mg twice a day on days 1-28 of a 28 day cycle.\n\nPomalidomide will be given 4mg daily for days 1-21 of each 28 day cycle. Dosing will be in the morning at approximately the same time each day.\n\ndexamethasone: 40mg will be given on days 1, 8, 15, 22 of a 28-day cycle\n\nclarithromycin: orally at a dose of 500 mg twice a day on days 1-28 of a 28 day cycle\n\nPomalidomide: orally 4mg daily for days 1-21 of each 28 day cycle","id":"OG000","title":"All Patients"}],"paramType":"MEAN","populationDescription":"18 patients were removed from study for reasons other then disease progression; 2 patients are still receiving treatment.","reportingStatus":"POSTED","timeFrame":"From start of treatment, to date of disease progression","title":"Time to Disease Progression (Progression Free Survival)","type":"SECONDARY","unitOfMeasure":"days"}